J. Rancourt

发表

Conformation-based restrictions and scaffold replacements in the design of hepatitis C virus polymerase inhibitors: discovery of deleobuvir (BI 207127).

C. Brochu, S. LaPlante, M. Bös, 2014, Journal of medicinal chemistry.

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

Steven R. LaPlante, P. Bonneau, D. Lamarre, 2003, Nature.

Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography.

J. Mercier, J. Rancourt, S. Titolo, 2013, ACS chemical biology.

N‐Chlorocarbonyl Isocyanate

J. Rancourt, 2008 .

Biphenylsulfonacetic Acid Inhibitors of the Human Papillomavirus Type 6 E1 Helicase Inhibit ATP Hydrolysis by an Allosteric Mechanism Involving Tyrosine 486

J. Rancourt, M. Massariol, E. Welchner, 2005, Antimicrobial Agents and Chemotherapy.

A systematic approach to the optimization of substrate-based inhibitors of the hepatitis C virus NS3 protease: discovery of potent and specific tripeptide inhibitors.

M. Poirier, J. Rancourt, M. Bailey, 2004, Journal of medicinal chemistry.

An NS 3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

P. Bonneau, D. Lamarre, P. Anderson, 2003 .

Cyclopropanation in vinyl radical cyclizations: The importance of structural constraints.

J. Rancourt, D. Gravel, R. Denis, 1993 .

Discovery of small-molecule inhibitors of the ATPase activity of human papillomavirus E1 helicase.

C. Brochu, J. Rancourt, P. White, 2004, Journal of medicinal chemistry.

An NS 3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

P. Bonneau, D. Lamarre, P. Anderson, 2003 .

Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: structure-activity relationships (SAR) of the C3-phenyl moiety.

J. Duan, O. Hucke, M. Garneau, 2013, Bioorganic & medicinal chemistry letters.

Distinct Effects of Two HIV-1 Capsid Assembly Inhibitor Families That Bind the Same Site within the N-Terminal Domain of the Viral CA Protein

Wesley I. Sundquist, Stephen W. Mason, W. Sundquist, 2012, Journal of Virology.

Generation of glycinyl radicals via a 1,5-hydrogen atom transfer reaction. Applications to γ-lactam formation

J. Rancourt, V. Gorys, E. Jolicoeur, 1998 .

Total regiospecific synthesis of the selagine tricyclic ring system

J. Rancourt, D. Gravel, D. Thoraval, 1984 .

Peptide-based inhibitors of the hepatitis C virus NS3 protease: structure-activity relationship at the C-terminal position.

Martin Poirier, D. Lamarre, M. Poirier, 2004, Journal of medicinal chemistry.

The effect of polar substituents on the conformation and stereochemistry of enolate radicals

B. Giese, J. Rancourt, F. Wetterich, 1993 .

Stereoselective hydrogen-transfer reactions involving acyclic radicals. A study of radical conformations using semiempirical calculations

Kathleen A. Durkin, J. Rancourt, D. Liotta, 1992 .

Chiral synthetic macrodiolide and macrotriolide ionophores with C2- and C2symmetry

J. Rancourt, W. Porter, S. D. Burke, 1990 .

Lewis acids in diastereoselective processes involving acyclic radicals

C. Chabot, J. Rancourt, B. Guérin, 1996 .

Role of .sigma.-Donation in the Stereocontrol of Hydrogen-Transfer Reactions Involving Acyclic Radicals

J. Rancourt, A. Slassi, G. Bantle, 1995 .

Anthranilic acid-based Thumb Pocket 2 HCV NS5B polymerase inhibitors with sub-micromolar potency in the cell-based replicon assay.

M. Garneau, S. LaPlante, R. Coulombe, 2013, Bioorganic & medicinal chemistry letters.

Discovery of a novel series of non-nucleoside thumb pocket 2 HCV NS5B polymerase inhibitors.

Louise Thauvette, Araz Jakalian, M. Bös, 2013, Bioorganic & medicinal chemistry letters.

The Use of Lewis Acids in Radical Chemistry. Chelation-Controlled Radical Reductions of Substituted α-Bromo-β-alkoxy Esters and Chelation-Controlled Radical Addition Reactions

J. Rancourt, Y. Guindon, 1998 .

Inhibitors of Respiratory Syncytial Virus Replication Target Cotranscriptional mRNA Guanylylation by Viral RNA-Dependent RNA Polymerase

J. Rancourt, M. Massariol, S. Landry, 2005, Journal of Virology.

Allosteric N-acetamide-indole-6-carboxylic acid thumb pocket 1 inhibitors of hepatitis C virus NS5B polymerase - Acylsulfonamides and acylsulfamides as carboxylic acid replacements

P. Kuhn, J. Duan, M. Garneau, 2013 .

Implementation of an electronic medical record in family practice: a case study.

France Légaré, Julie Duplantie, Jean-Paul Fortin, 2010, Informatics in primary care.

Stereoselective chelation-controlled reduction of .alpha.-iodo-.beta.-alkoxy esters under radical conditions

J. Rancourt, Y. Guindon, J. Lavallée, 1991 .

Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease.

D. Lamarre, J. Rancourt, M. Bailey, 1998, Bioorganic & medicinal chemistry letters.

Highly potent and selective peptide-based inhibitors of the hepatitis C virus serine protease: towards smaller inhibitors.

D. Lamarre, J. Rancourt, M. Bailey, 2000, Bioorganic & medicinal chemistry letters.

Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements.

J. Proudfoot, L. Tong, E. Hickey, 1999, Journal of medicinal chemistry.